Ischemic Cardiomyopathy
📧 Sign up to get email alerts when something new happens for Ischemic Cardiomyopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-04-10Clinical Trial Update: Randomized Evaluation and Verification of Ventricular Enhancement [NA]
A randomized evaluation and verification of a ventricular enhancement system by BioVentrix for ischemic cardiomyopathy and heart failure has…
-
CLINICAL_TRIALS withdrawal · 2018-04-10Clinical Trial Update: RANOLAZINE STUDY: Speckle Tracking Derived Myocardial Strain
The Ranolazine study evaluating speckle-tracking derived myocardial strain has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-07Clinical Trial Update: Virtual LV Lead Navigation in Patients With Ischemic Cardiomyopathy [NA]
A clinical trial (NCT01825239) evaluating virtual LV lead navigation in patients with ischemic cardiomyopathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-02-12Clinical Trial Update: REgenerative CardiOsphere iNjection to STRengthen dysfUnCTional Hearts [Phase 1]
A Phase 1 clinical trial evaluating REgenerative CardiOsphere iNjection for ischemic cardiomyopathy was withdrawn; the study also involved c…
-
CLINICAL_TRIALS withdrawal · 2013-12-04Clinical Trial Update: Stem Cell Implantation in Patients Undergoing CABG [Phase 1]
A Phase 1 trial evaluating stem cell implantation in patients undergoing CABG was terminated; Miltenyi Biotec is the sponsor.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.